[Treatment of rheumatoid diseases].
D000208:Acute Disease; D000251:Adenosine Triphosphatases / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000096:biosynthesis; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D016918:Arthritis, Reactive / Q000188:drug therapy; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000201:enzymology; D002908:Chronic Disease; D004357:Drug Synergism; D005258:Felty Syndrome / Q000188:drug therapy; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D012217:Rheumatoid Factor / Q000378:metabolism; D012859:Sjogren's Syndrome / Q000188:drug therapy; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D006046:Gold; D000255:Adenosine Triphosphate; D012217:Rheumatoid Factor; D000251:Adenosine Triphosphatases
Leczenie choròb reumatoidalnych.